Cencora (STU:ABG) Change In Payables And Accrued Expense : €4,529 Mil (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Cencora Change In Payables And Accrued Expense?

Cencora's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €887 Mil. It means Cencora's Accounts Payable & Accrued Expense increased by €887 Mil from Jun. 2024 to Sep. 2024 .

Cencora's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2024 was €4,426 Mil. It means Cencora's Accounts Payable & Accrued Expense increased by €4,426 Mil from Sep. 2023 to Sep. 2024 .

Cencora Change In Payables And Accrued Expense Historical Data

The historical data trend for Cencora's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Change In Payables And Accrued Expense Chart

Cencora Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

3,204.75

1,906.66

2,558.75

5,583.04

4,425.81

Cencora Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															2,592.14	1,435.66	-1,237.84	3,444.04	887.25

Cencora Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,529 Mil.

Cencora Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cencora's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (STU:ABG) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

COR:USA COR:Mexico 0HF3:UK ABG:Germany C1CO34:Brazil

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.